The DIABETES FACE TO FACE brand, founded in 2008 (United States), from 588 sister brands and 17477 competing brands. The DIABETES FACE TO FACE brand is owned by ELI LILLY AND COMPANY, a company listed in New York. DIABETES FACE TO FACE is part of the Drug Manufacturers activity sector.

DIABETES FACE TO FACE is a brand of ELI LILLY AND COMPANY (LLY) Share price

International deposit : 2008 Business sector Drug Manufacturers

Share price and profitability of the share ELI LILLY AND COMPANY (DIABETES FACE TO FACE)

Buy ELI LILLY AND COMPANY share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 733.51

Portfolio valuation
ELI LILLY AND COMPANY (DIABETES FACE TO FACE) over 5 years* USD 4,558.17

Stock market history ELI LILLY AND COMPANY (DIABETES FACE TO FACE)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
ELI LILLY AND COMPANY

POINT BIOPHARMA
POINT BIOPHARMA
DICE MOLECULES
DICE MOLECULES
DICE Therapeutics
DICE Therapeutics
Versanis
Versanis
ChemGen
ChemGen
Pharmaserve-Lilly
Pharmaserve-Lilly
See more brands of ELI LILLY AND COMPANY

Rival brands
DIABETES FACE TO FACE

Icosavax
Icosavax
OGX
OGX
MAUI MOISTURE
MAUI MOISTURE
POLYSPORIN
POLYSPORIN
LACTAID
LACTAID
ZARBEE'S
ZARBEE'S
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands > Pricing Power > 5 major sectors
Desirable brands > Pricing Power > 5 major sectors

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS